Cargando…
Cotrimoxazole‐induced hyperkalemia in renal transplant patient—Case report
We present the case of a 55‐year‐old male patient who developed hyperkalemia after using Cotrimoxazole (TMP‐SMX). There was a marked increase in potassium levels from 3.3 mEq/L on Day 5 when cotrimoxazole was started to 6.2 mEq/L on Day 11 when the drug was withheld.
Autores principales: | Srikaram, Prakhyath, Siddiqui, Amna, Gul, Fahad, Deuja, Puja, Fatima, Nabeela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585223/ https://www.ncbi.nlm.nih.gov/pubmed/36285028 http://dx.doi.org/10.1002/ccr3.6509 |
Ejemplares similares
-
Scleroderma and interstitial lung disease - A case report
por: Gul, Fahad, et al.
Publicado: (2022) -
A transplant compatible with all patients: A salvage underway
por: Srikaram, Prakhyath, et al.
Publicado: (2022) -
Cotrimoxazole Induced Steven Johnson Syndrome: A Case Report
por: Acharya, Ayushma, et al.
Publicado: (2020) -
Cotrimoxazole: Stevens-Johnson syndrome: case report
Publicado: (2021) -
Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia
por: Marfo, K., et al.
Publicado: (2012)